Pair Name | Carvacrol, Sorafenib | ||
Phytochemical Name | Carvacrol (PubChem CID: 10364 ) | ||
Anticancer drug Name | Sorafenib (PubChem CID: 216239 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Sorafenib |
Adverse Reactions | Facial red macules, dry skin, acne, alveolitis. This was inferred hot nature anticancer drug. |
Recommendations | Cold: Ilex hainanensis; Mangifera indica; Camellia sinensis; Sophora flavescens; Eriobotrya japonica; Citrus aurantium; |
Reference | Malignant tumors in the era of immunotherapy based on traditional Chinese medicine's "cold and hot theory" Construction of integrated traditional Chinese and Western medicine treatment paradigm[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine,2023,32(12):1712-1716. DOI:10.3969/j.issn.1008-8849.2023.12.022. ref_link |
Pair Name | Carvacrol, Sorafenib | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Inhibition-->Epithelial-mesenchymal transition | |||
Gene Regulation | Down-regulation | Expression | ABCG2 | hsa9429 |
Up-regulation | Expression | BAX | hsa581 | |
Down-regulation | Expression | BCL2 | hsa596 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Up-regulation | Expression | GSS | hsa2937 | |
Down-regulation | Expression | HIF1A | hsa3091 | |
Up-regulation | Expression | IL6 | hsa3569 | |
Down-regulation | Expression | LDHA | hsa3939 | |
Down-regulation | Expression | NOTCH1 | hsa4851 | |
Down-regulation | Expression | SALL4 | hsa57167 | |
Down-regulation | Expression | TGFB1 | hsa7040 | |
Up-regulation | Expression | TNF | hsa7124 | |
Down-regulation | Expression | TRPM7 | hsa54822 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
Down-regulation | Expression | VIM | hsa7431 | |
In Vivo Model | A preliminary study was conducted using 200 mg/kg of TAA dissolved in 0.2 mL of normal saline and given intraperitoneal (i.p.) twice a week for 16 weeks to induce HCC. | |||
Result | CARV/Sora is a promising combination for tumor suppression and overcoming Sora resistance and cardiotoxicity in HCC by modulating TRPM7. To our best knowledge, this study represents the first study to investigate the efficiency of CARV/ Sora on the HCC rat model. Moreover, no previous studies have reported the effect of inhibiting TRPM7 on HCC. |
No. | Title | Href |
---|---|---|
1 | Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7. Life Sci. 2023 Jul 1;324:121735. doi: 10.1016/j.lfs.2023.121735. | Click |